Two of the posters feature baseline methodologies and a 36-month analysis of myopia progression in a globally diverse population of 282 patients. The third poster highlights the benefits of SYD-101.

The research presents a meticulous analysis of plasma-to-tissue concordance across various cancer types, offering valuable insights into the considerations for validation, using Illumina's cutting ...

For this year’s poster presentation, abstracts were submitted by undergraduate students, graduate students, post-doctoral scholars, residents, and associate fellows. Each poster was judged on ...

Obsidian will also present preclinical data from a multimodal phenotyping analysis comparing OBX-115 TIL generated with its proprietary manufacturing process to conventional, non-engineered TIL ...

Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025 Provided by PR Newswire Apr 25, 2025, 4:02:00 PM ...

Opna Bio Announces 2024 ASH Presentations Highlighting Interim Data from Phase 1 Combo Study of BET Inhibitor OPN-2853 with Ruxolitinib in Myelofibrosis, and Promising Preclinical Data with EP300 ...